Manipal Hospitals
Lung cancer treatment cost in India typically begins with essential diagnostics such as a PET-CT scan, which runs AUD $580 to AUD $870. Primary treatments include lung cancer surgery from Price on request to Price on request , or chemotherapy for lung cancer costing Price on request to Price on request . Expenses depend on cancer stage, hospital choice, and required technologies. Patients save approximately 70–80% compared to Australia, with top care found in Delhi, Bengaluru, and Chennai.
Typical Lung Cancer Treatment Costs in India
Bookimed Expert Insight: Advanced surgical cases benefit from robotic assistance to reduce recovery times. Fortis Gurgaon is recognized as a technically advanced facility for robotic oncology. For complex lung procedures, Global Hospital Chennai performed India's first minimally invasive lung transplant. Patients requiring precise radiation may prefer Dr. Rela Institute, which uses linear accelerators with 1 mm accuracy. Specialists like Dr. Surender Dabas have performed 8,000+ thoracic and head procedures.
| India | Thailand | Turkey | |
| Immunotherapy with Keytruda (Pembolizumab) | from AUD $5,077 | from AUD $11,605 | from AUD $4,787 |
No hidden fees – just official clinic prices. Pay at the clinic for Lung cancer treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lung cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lung cancer treatment journey.
Professor Raja Sundaram has successfully performed over 15,000 surgical procedures, making him one of the most prolific surgical oncologists in the region.
Professor Dabas is a leading thoracic specialist who has performed over 8,000 surgeries for head, neck, and chest tumours. He currently serves as the Director of Surgical Oncology and Chief of Robotic Surgery at BLK Cancer Centre.
Professor Nagarkar has performed over 50,000 cancer surgeries and leads the HCG Manavata Cancer Centre. He focuses on thoracic surgical oncology for tumours within the chest and lungs.
Professor Vadhiraja B. M. is a senior radiation oncologist at Manipal Hospitals, where he specialises in pinpointing and treating lung tumours.
Indian medical centres offer a full range of lung cancer treatments. These include minimally invasive robotic surgery, immunotherapy, and high-precision radiation. Specialists at JCI-accredited hubs like Apollo Hospital Indraprastha use multidisciplinary teams. They design plans based on the cancer stage and molecular type.
Bookimed Expert Insight: Indian oncology centres often offer decision-support technologies like IBM Watson. Hospitals such as Manipal use this to analyse clinical data against global literature. This helps doctors select the most effective chemotherapy or targeted drug protocols.
Patient Consensus: Patients note the importance of completing molecular biomarker testing before starting therapy in India. They frequently highlight the 24-hour support from coordinators. They suggest confirming the full cost of follow-up scans and pathology before beginning treatment.
Indian oncology centres offer biomarker and genetic testing for lung cancer patients. Leading facilities use Next-Generation Sequencing (NGS) and liquid biopsies to identify targets like EGFR, ALK, and PD-L1. These tests guide personalised immunotherapy and targeted treatments at accredited laboratories.
Bookimed Expert Insight: Indian cancer centres specialise in high-volume genomic data. HCG Manavata Cancer Centre has participated in over 200 clinical trials. Dr Shaunak Valame there focuses on the molecular basis of cancer and targeted therapies. This research depth means patients often access new testing protocols early.
Patient Consensus: Patients note that larger Indian centres integrate molecular testing into treatment plans. They recommend checking if the biopsy sample is large enough for full profiling. Do this before starting immunotherapy.
Indian medical facilities manage Stage 4 lung cancer using international protocols focused on extending survival. JCI-accredited centres provide systemic therapies like immunotherapy and targeted therapy based on molecular profiling. Specialists use technologies such as CyberKnife and robotic systems to treat metastases and control symptoms.
Bookimed Expert Insight: Indian oncology focuses heavily on volume-based expertise. Dr Raj Nagarkar at HCG Manavata has performed over 50,000 cancer surgeries. This high case frequency helps Indian specialists manage complex Stage 4 complications. Many centres also use IBM Watson software to support treatment decisions with global data.
Patient Consensus: Patients note that large private hospitals in Indian cities provide coordinated care. These facilities house oncology, pathology, and palliative services in one building. Those travelling to clinics like BLK Super Speciality praise the constant support from coordinators.
Lung cancer success rates in India vary by stage. For tumours under 2 cm detected early, 5-year survival reaches 80% to 90%. Centres like Apollo Hospital Indraprastha and Manipal Hospitals provide JCI-accredited care. They report a 71.75% disease control rate during first-line therapy.
Bookimed Expert Insight: Indian oncology is defined by massive case volumes and specialised surgical expertise. Dr Surender Dabas at BLK Super Speciality Hospital has performed 8,000 procedures. Dr Raja Sundaram at Global Hospital Chennai has handled over 15,000 surgeries. Surgeons here often manage complex thoracic cases more frequently than specialists in smaller markets.
Patient Consensus: Patients find that outcomes depend heavily on molecular testing and early surgical intervention. They note that high-volume centres provide faster access to second opinions. Multidisciplinary teams are also vital for managing advanced cases.
Mumbai, Delhi NCR, Chennai, and Bengaluru are the main hubs for lung cancer treatment in India. These cities house JCI-accredited facilities and specialise in medical interventions. Patients access proton beam therapy, robotic-assisted thoracic surgery, and complex genomic profiling for targeted immunotherapy.
Bookimed Expert Insight: Surgical volume is a critical quality indicator in Indian oncology centres. Dr Raj Nagarkar and Dr Raja Sundaram have each performed over 15,000 to 50,000 cancer surgeries. This immense experience often leads to more refined techniques in thoracic resections.
Patient Consensus: Patients often praise the 24-hour support from coordinators and the efficient medical teams in India. They note that receiving results and treatment plans quickly is a significant benefit.